- Veraflox® (pradofloxacin) is characterized by favourable Minimum Inhibitory Concentrations (MIC) for an extended spectrum of veterinary pathogens.
- Compared to other veterinary fluoroquinolones, MICs of pradofloxacin are significantly lower for Gram-positive bacteria including staphylococci and streptococci as well as anaerobic bacteria, and they are also lowest for Gram-negative bacteria.
- Pradofloxacin acts in a bactericidal manner with a very high rate of kill. Additionally, it has very low mutant prevention concentrations (MPC). These features may contribute to the minimisation of resistance selection during treatment. Thus, Veraflox® facilitates a highly efficacious and very rational antibacterial therapy for dogs and cats.